Value of D-Dimer in Risk Stratification for Thromboembolism in Patients With Atrial Fibrillation and Low CHA2DS2-VASc Score
Atrial fibrillation (AF) can cause thrombi formation and subsequent emboli deposition in systemic arteries, leading to various organ ischemia and infarction. Anticoagulation therapy can reduce the risk of thrombus formation and embolization, and is initiated based on a patient's risk score, whi...
Saved in:
Main Authors: | Po-Han Chen BS (Author), Mark Schwade MD (Author), Gyanendra Sharma MD (Author), Vincent J. B. Robinson MD (Author) |
---|---|
Format: | Book |
Published: |
SAGE Publishing,
2023-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Thromboprophylaxis in atrial fibrillation: correct interpretation and effective use of CHA2DS2-VASc and HAS-BLED scores
by: Mateusz Wawrzeńczyk, et al.
Published: (2023) -
Total Adiponectin Is Inversely Associated with Platelet Activation and CHA2DS2-VASc Score in Anticoagulated Patients with Atrial Fibrillation
by: Roberto Carnevale, et al.
Published: (2014) -
Association of epicardial adipose tissue thickness and inflammation parameters with CHA2DS2-VASc score in patients with nonvalvular atrial fibrillation
by: Akdag S, et al.
Published: (2015) -
Status of CHADS2 and CHA2DS2-VASc Scores in Predicting Risk of Stroke and its Prevention in Iraqi Patients with Atrial Fibrillation
by: Mohanad Yasir Radeef
Published: (2019) -
Status of CHADS2 and CHA2DS2-VASc Scores in Predicting Risk of Stroke and its Prevention in Iraqi Patients with Atrial Fibrillation
by: Mohanad Y. Al-Radeef
Published: (2019)